Tag: Vivek Vishwanathan
Trilegal acts for JB Pharmaceuticals on Novartis acquisition
Trilegal advised JB Pharmaceuticals in its acquisition of a portfolio of specific ophthalmology brands from Novartis for INR10.9 billion
Trilegal advised JB Pharmaceuticals in its acquisition of a portfolio of specific ophthalmology brands from Novartis for INR10.9 billion
South Korea’s maritime hub status grows with advanced ports, shipbuilding strength, trade volumes and dispute resolution.
Follow us on LinkedIn